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the cost of 3 strategies: 1) axillary lymph node dissection; 2) sentinel lymph node
biopsy followed by distant axillary lymph node dissection in case of positive sen-
tinel lymph node; and and 3) sentinel lymph node biopsy with intra-operative
histological examination and axillary lymph node dissection for positive cases. A
multivariate probabilistic sensitivity analysis was conducted on identification rate,
complication rates, sensitivity, specificity and length of hospital stay. RESULTS:
The sentinel mph node biopsy is less costly than lyaxillary lymph node dissection
in the early stages of breast cancer. Intra-operative histological examination of
sentinel lymph node significantly reduces the cost of the procedure. Data on mo-
lecular intra-operative examination couldn’t be integrated in the present study as
no French cost data were available. In a systematic review, no survival difference
could be demonstrated between the three strategies in early stage of breast cancer
and quality of life was found to be better with sentinel lymph node biopsy than
with axillary lymph node dissection. Nevertheless, more data are needed to inte-
grate these results in a cost-effectiveness analysis. CONCLUSIONS: The study con-
firms the interest of sentinel lymph node biopsy in early stage of breast cancer. The
cost comparison helps to determine the choice of the intervention alongside other
arguments as women’s preference, efficacy and safety.
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OBJECTIVES: The advent of robotic surgery to prostate cancer treatment has been
justified by improved convalescence, fewer medical complications and decreased
morbidity in comparison with traditional operating techniques. Furthermore, ro-
botic surgery has been claimed to achieve better results concerning urinary conti-
nence and sexual factors. Our aim was to find out whether these claims are realized
in an unselected material of a large university hospital. METHODS: An ongoing
observational follow-up study in the real-world setting of a university hospital
using the 15D generic health-related quality of life (HRQoL) instrument. Patients
entering for treatment of prostate cancer were asked to fill in the HRQoL question-
naire at baseline and 3, 6, 12 and 24 months after entering treatment. RESULTS: So
far, 123 patients have undergone surgery: 76 in the robot-assisted laparoscopic
prostatectomy group (RALP, mean age 60.6 years) and 47 in the open surgery group
(OS, mean age 61.5 years). The baseline prognostic Gleason score did not differ in a
statistically significant manner between the groups (6.91 vs. 6.98, p0.593). The
mean HRQoL score in the OS group was slightly lower at baseline than that in the
RALP group (0.940 vs. 0.920), but the difference was not statistically significant.
During the two-year follow-up the HRQoL score remained slightly lower in the OS
group at all follow-up points, but none of the differences was statistically signifi-
cant. At the three-month follow-up the RALP group fared statistically significantly
better on the dimensions of “excretion” (p0.05) and “sexual activity” (p0.01), but
at the subsequent follow-up points the statistically significant difference had dis-
appeared. The dimension of “vitality” did not differ between the groups at any of
the follow-up points. CONCLUSIONS: The benefit from robot-assisted prostate sur-
gery was in our material so small that it probably does not offset the high cost
associated with the robotic approach.
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OBJECTIVES: Immediate or early breast reconstruction (BR) a viable option for the
majority of women with breast cancer. However, only 5.6% of the mastectomy
patients underwent BR in Taiwan. Quantitative evidence on the preferences of
women for BR is limited; this study, therefore, elicits such preferences. METHODS:
Face to face patient interviews were conducted on 156 women who had previously
undergone a therapeutic mastectomy, of whom 60 had also undergone a BR. These
women were asked to choose between hypothetical BR profiles featuring six attri-
butes: (1) material used for reconstruction, (2) number and duration of operations,
(3) failure rate, (4) aesthetic result and (5) out-of-pocket payment (in NT$), and
additionally had the option to choose not to undergo BR. The relative importance of
attributes and trade-offs that the patients were willing to make among them were
examined using a conditional logit regression model. RESULTS: Coefficients for all
treatment attributes were significant with a prior expected direction. Women had
a significant positive preference for autologous tissues, shorter operations, ‘excel-
lent’ aesthetic results, a reduction in failure rate and in out-of-pocket payments.
Expected 1% reductions in the chance of failure were associated with a willingness
to pay of $NT40,000. Women would be willing to pay NT$22,000 to replace implants
with autologous tissues, NT$81,000 to reduce operation time from 8 hours to 2
hours, and NT$86,000 to increase the aesthetic result from ‘excellent’ to
‘moderate’. CONCLUSIONS: These findings provide insight into how BR are viewed
and valued by women, and how future advances in surgical techniques will in-
crease the uptake of BR by meeting women’s preferences for reduction in length of
time of operations and failure rate, as well as improvement in aesthetic results.
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OBJECTIVES: The collection of pre- and post-operative Patient Reported Outcome
(PROs) have traditionally been used to assess the benefit of medical and surgical
interventions. More recently, individual patient level PROs have been used in ev-
eryday clinical practice. Online website ‘electronic’ collection, so called remote
ePROs, provides a platform to collect scores at regular intervals and report results
back to both patients and their clinicians. Chronic conditions can then be moni-
tored over time to compare the response to treatment with that of other patients.
The primary aim of this study was to assess whether scores collected electronically
via an online internet website (ePROs) are equivalent to scores collected via the
traditional pen and paper format (PROs). METHODS: A group of 47 patients, who
had previously undergone open hip debridement for femeroacetabular impinge-
ment, were allocated to one of two groups as part of a randomized crossover study.
As per the ‘International Society for Pharmacoeconomics and Outcomes Research
(ISPOR) ePRO Good Research Practices Task Force Report’, this study was powered
to rule out a difference between PRO and ePRO assessment of 0.3 standard devia-
tions. Group 1 completed the online ePRO scores- Oxford, McCarthy, UCLA and
HowRu score- followed by the PRO paper equivalents one week later, and Group 2
completed the scores in reverse order.RESULTS:The difference between the online
ePRO and paper PRO Oxford score in Group 1 was 1.6, 0.9 to 2.4 (mean, 95% confi-
dence interval (CI)) and in Group 2 was 0.8, 0.2 to 1.3 (mean, 95% CI). There was no
significant difference between Group 1 and Group 2. Therefore analysis revealed an
ePRO Oxford score of 32.8, 29.7 to 35.8 (mean, 95% CI) and a PRO score of 33.0, 29.9
to 36.1 (mean, 95% CI). CONCLUSIONS: Remote online ePRO score collection using
this website is equivalent to paper PRO collection.
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OBJECTIVES: Vertebral compression fractures (VCFs) are a fairly common and
painful result of cancer but little is known about the quality of life (QoL) in these
patients. The randomised controlled trial (RCT) CAFE, comparing balloon kyphop-
lasty (BKP) to non-surgical management (NSM), is the only RCT that has been
conducted in cancer patients with VCFs. The objective of this study was to use data
from CAFE to analyse QoL in cancer patients with VCFs and to analyse the impact
of BKP on QoL in these patients. METHODS: SF-36 data from the CAFE study were
analysed. Answers to the SF-36 questionnaire were translated into eight subcate-
gories which in turn were mapped to health utilities. At baseline, complete data
were available for 55 patients in the control group 65 patients in the treatment
group; both groups had lost seven at 1 month’s follow-up. Although the original
study ran for 12 months, high crossover rates from control group to treatment after
1 month posed a challenge to an analysis of long-term QoL effects. RESULTS: At
baseline, the NSM group had a mean utility (SE) of 0.27 (0.027) while the BKP group
had 0.30 (0.027). After 1 month, the NSM group had a utility of 0.30 (0.030) and the
BKP group 0.63 (0.029). The difference in utility at 1 month (0.33) was statistically
significant (p0.001). No significant differences in baseline QoL or QoL impact of
BKP were observed between different underlying cancer types. . Health utilities
appeared to be relatively stable between 1 month and 12 months. CONCLUSIONS:
VCFs in cancer patients are associated with significant QoL impairment. QoL is
meaningfully improved by treating painful VCFs with BKP, independently of the
underlying cancer type. This information can be used as a basis for further re-
search, such as analyses of the cost-effectiveness of BKP.
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OBJECTIVES: Liver transplantation (LTx) is indicated in familial amyloid polyneuropathy
(FAP) to prevent long term disease progression. This study aims to assess health-related
quality of life (HRQoL) in FAP patients before and after LTx. METHODS: A systematic
review was conducted by January 2012 through Cochrane Collaboration, Medline,
EMBASE, and Lilacs databases. Outcome measures were mental and physical di-
mensions assessed by HRQoL questionnaires. RESULTS: Five studies met eligibility
criteria. Before LTx, FAP patients presented lower scores measured by EuroQol
(EQ-5D) index when compared to general population (18-34 years: 0.810.02; 35-49
years: 0.680.03; 50-64 years: 0.570.04; 65 years: 0.580.05 versus 0.920.00;
0.880.00; 0.840,00, and 0.790,00, respectively; p0.0001 for all comparisons).
When compared to other chronic diseases, FAP presented a significantly worse
HRQoL (FAP[50-64 years]: 0.58; diabetes: 0.76; stroke: 0.69; emphysema: 0.68; heart
failure: 0.64; rheumatoid arthritis: 0.66; p 0.0001 for all comparisons). After LTx,
HRQoL assessed by Short Form Health Survey (SF-36) was lower in FAP when com-
pared to non-PAF transplanted patients (p0.04). Physical and emotional well-
being domains 4 years after transplantation were significantly lower compared to
non-FAP transplanted (physical:35%-75%; emotional: 24%-54% reduction) and gen-
eral population (physical:16%-55%, emotional: 10%-39% reduction). A new score
was developed to measure the difference between HRQoL at 6 months after and
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before transplantation in FAP and non-FAP patients. Mental component improved
in non-FAP (18.47) and worsened in FAP (-7.8) after transplantation. Physical com-
ponent showed improvement in both groups, but significantly greater in non-FAP
group (8.00 versus 16.76). Worst HRQoL scores were associated to limbs pain, dis-
ability, and mental symptoms. LTx must be performed early, before the onset of
somatic symptoms to improve chances of a better HRQoL. CONCLUSIONS: FAP
patients submitted to LTx present worse HRQoL scores when compared to non-FAP
transplanted patients. After LTx, FAP present worse mental component; physical
component showed improvement, but significantly lower than non-FAP group.
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OBJECTIVES: Familial amyloid polyneuropathy (FAP) is an autosomal dominant
disorder, caused by mutant transthyretin protein (TTR). Because most TTR is pro-
duced in hepatocytes, liver transplantation (LTx) has been a treatment option to
prevent long term disease progression. This study aims to report demographic and
clinical characteristics of FAP patients submitted to LTx in Brazil compared to FAP
World Transplant Registry (FAPWTR). METHODS: A literature review was per-
formed by May 2012 through Cochrane Collaboration, Medline, EMBASE, and Lilacs
databases. A retrospective analysis of epidemiological data available from FAPWTR
was developed from 1995 to 2010. RESULTS: From 1995 to 2010, 1,893 LTx were
recorded in 73 centers of 19 countries by FAPWTR. Of these, 5% were performed in
4 Brazilian centers. In FAPWRT cohort, 56% were male, median age at time of
transplantation was 38 years (21-72), and the median disease duration before LTx
was 3 years (0-30). The main causes of death were cardiac complications (22%),
sepsis (22%), liver related complications (14%) and perioperative complications
(3%). The 5-year survival rate was 82%. In a cohort from São Paulo University-Brazil,
24 patients underwent LTx. Patients characteristics were similar to FAPWRT (66.6%
male; median age 36 years), except for disease duration before transplantation
(median: 8 years [2-17]). Six deaths were registered and the main causes were
sepsis and hepatic artery thrombosis. Cardiac related deaths was also observed but
in one case. The overall 5-year survival rate was 58%. Data from 59 Brazilian sub-
jects enrolled in Transthyretin Amyloidosis Outcomes Survey (THAOS) indicated
81% of symptomatic patients and LTx performed in 37.5%. CONCLUSIONS: When
compared to FAPWTR, Brazilian cohort showed longer disease duration before LTx,
and a shorter 5-year survival rate after the procedure. This might be indicative of a
need for better diagnose and management of FAP patients in Brazil.
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OBJECTIVES: Liver transplantation (LTx) is a complex surgical procedure indicated
for patients with serious acute or chronic diseases, when no other effective treat-
ment is available. This retrospective study aims to report temporal trends and
geographic distribution of LTx in Brazil. METHODS: A systematic review was per-
formed by May 2012 to identify publications on LTx in Brazil through Cochrane
Collaboration, Medline, EMBASE, Lilacs databases and gray literature. A retrospec-
tive analysis of epidemiological data available from Brazilian Registry of Trans-
plants (Brazilian Association of Organ Transplants) and Report of Latin American
Transplantation (The Transplantation Society of Latin American and The Carib-
bean) was developed from 1985 to 2011. RESULTS: In Brazil, an increase in LTx
performed annually was observed since the first successful experience (1985). In
2011 1,492 LTx were performed, an increase of 496% over 5 procedures in 1985, with
a survival rate of 74% for patients and 70% for graft. Living donor procedures
showed an increase from 1995 to 2005, but a reduction after 2006 (5 in 1995; 192 in
2005; 104 in 2011). Deceased donor procedures present a continuous growth ten-
dency (3 in 1985; 1,388 in 2011). Nevertheless, in 2009, the waiting list had 4,850
registered patients. Geographic distribution is influenced by transplantation cen-
ters distribution. The distribution of [inhabitants; LTx centers; LTx procedures] in 5
Brazilian geographic region in 2011 is: North [8.09%; 0%; 0%], Northeast [27.97%;
15.79%; 21.24%], Midwest [7.32%; 2.63%; 0%], Southeast [42.20%; 60.53%; 57.92%],
and South [14.43%; 21.05%; 20.84%]. São Paulo state, placed in Southeast region,
represents 31 transplantation centers (76 in Brazil), 21.58% of country population
and 46% of LTx conducted in 2011. CONCLUSIONS: Brazil performed a growing
number of LTx from 1985 to 2011, but this increase may not be enough, once a large
patient’s number remains on waiting lists. Geographical distribution shows to be
significantly irregular in the country.
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OBJECTIVES: Recent recommendations (1) have underscored the need for anemia
assessment and treatment, including iron, prior to scheduled orthopedic surgery.
Administration of intravenous iron alone or combined to erythropoiesis stimulat-
ing agents (ESA) have also been shown to reduce transfusion requirements. How-
ever, the current practices are not well known. The aim of the present study was to
assess the management of iron supplementation and anemia in patients with
scheduled hip or knee surgery. METHODS: A total of 718 Anesthesiologists were
selected from a professional file. Their daily practice on anemia management was
evaluated through a questionnaire. RESULTS: The survey analysis was performed
on 117 questionnaires (return rate: 16%). The most frequent biological exams for
anemia and iron deficiency prescribed by surgeons (45%), anesthesiologist (48%) or
both (7%) before surgery were hemoglobin (100% of questionnaires), ferritin (35%),
serum iron (33%), transferrin and Transferrin saturation (24%). Among the 117
anesthesiologists, 94 (80.3%) declared to prescribe ESA and 104 (89%) iron (oral, 29%;
intravenous, 17%; both, 50%) before surgery. The main reasons to choose intrave-
nous iron were combination to ESA (54%), short delay before surgery (43%), poor
tolerance of oral iron (37%) or poor intestinal absorption (27%); intravenous iron
was also used in the absence of ESA for 37%. In case of anemia after surgery,
intravenous iron given in the first 24 hours was prescribed by 80% of anesthesiol-
ogist. When patient returned home, 65% of survey responders prescribed oral iron.
CONCLUSIONS:This survey shows that optimization of Hemoglobin before surgery
with the use of ESA and iron is wide, but the exploration of anemia is infrequent,
despite recent recommendations. Prospective studies aimed to assess the impact
of intravenous iron alone or combined to ESA before elective orthopedic surgery are
necessary. Prospective studies aimed at better defining the place of iron are still
needed.
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OBJECTIVES: Using information collected from leading Turkish gynecologists, the
costs of different clinical practices of laparoscopic surgery (LS) for endometriosis
treatment were compared. METHODS: Top gynecologists from Turkey were inter-
viewed regarding the best practices to treat endometriosis, including hospitaliza-
tion, tests ordered pre- and post surgery, and the number of follow-up visits per
patient. Physicians’ views were split into two camps with a few opinions in the
middle. The diverging physician opinions were compared and using the physi-
cians’ recommended laparoscopy procedures, the cost of endometriosis treatment
was estimated using Social Security Institution data. RESULTS: The answers re-
garding hospitalization following laparoscopic surgery differed between “hospital-
ization for all patients” and “no hospitalization” after LS. The percentage of pa-
tients recommended for chest radiography and electrocardiogram (ECG) also
varied between 30% and 100%. The number of follow-up visits differed with sug-
gestions for both no and one follow-up visit. Using the interview results and the
assumption that 5% of Turkish women between ages 18 and 49 (N1,000,000) suffer
from endometriosis, the total cost of laparoscopic treatment was estimated for two
sets of recommendations: a) the physician does not hospitalize patients, suggests
chest radiography and ECG for 30% of patients, and does not follow-up with any of
the patients after LS, and b) the physician hospitalizes all patients for one night,
suggests chest radiography and ECG for 100% of patients, and follows-up with all
patients after LS. Depending on physicians’ preference of treatment procedures,
projected costs varied from 200.24, to 241.30. CONCLUSIONS: Different clinical
perspectives and practices of laparoscopic treatment for endometriosis affect cost
of therapy by as much as 41,06 per patient. When combined with the estimated 1
million endometriosis patients in Turkey, total cost differs 41,060,000. Developing
a standard procedure for LS may help lower aggregate costs and cost variation of
procedure.
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OBJECTIVES: Examine the association between degenerative disk disease (DDD)
and patient length of stay (LOS) and total payments among patients who under-
went lumbar fusion surgery. METHODS: Patients who underwent an anterior lum-
bar interbody fusion (ALIF), posterior lumbar fusion (PLF) or transforaminal or pos-
terior lumbar interbody fusion (T/PLIF) surgery over the time period from 2006 -
2009 in the Thomson Reuters MarketScanÒDatabases were identified. These pa-
tients were examined for evidence of degenerative disk disease (DDD). Multivariate
regressions were used to examine the association between DDD and LOS and total
payments, while controlling for patient age, sex, type of insurance coverage, and
type of procedure. RESULTS: Of the 28,647 patients who underwent lumbar fusion
surgery, 7,230 had an ALIF, 16,374 had a PLF, and 5,043 had a T/PLIF. 13,340 (46.57%)
of the sample had a comorbid diagnosis of DDD (ICD-9 code 722.6x, 722.51, 722.52).
However, the majority of these patients were also diagnosed with an additional
comorbid back problem - only 1,911 (6.67%) were diagnosed with stand alone
DDD. Compared to patients without DDD, patients who had DDD and no additional
comorbid back problem were found to have $5,557 lower total payments (P0.0001)
and 0.17 shorter LOS (P0.0001), after controlling for patient characteristics and
type of procedure. In contrast, patients with DDD and an additional comorbid back
diagnoses were found to have $4,876 higher total payments and 0.07 longer LOS
compared to patients without DDD. CONCLUSIONS: DDD is an uncommon sole
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